Your browser doesn't support javascript.
loading
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.
Franquet, Elisa; Palmer, Mathew R; Gifford, Anne E; Selen, Daryl J; Chen, Yih-Chieh S; Sedora-Roman, Neda; Joyce, Robin M; Kolodny, Gerald M; Moss, Alan C.
Afiliação
  • Franquet E; aDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology bDivision of Gastroenterology, Department of Medicine cDivision of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA dDepartment of Medicine, Universidad Autónoma de Barcelona (UAB), Barcelona, Spain.
Nucl Med Commun ; 35(10): 1026-31, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25076161

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifamicinas / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Mucosa Intestinal / Intestinos / Antibacterianos Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifamicinas / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Mucosa Intestinal / Intestinos / Antibacterianos Idioma: En Ano de publicação: 2014 Tipo de documento: Article